Results 131 to 140 of about 422,600 (405)

Pharmacists’ Attitudes toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature

Substance Abuse, 2019
Background Pharmacists are on the frontline caring for patients at risk of an opioid overdose and for patients with an opioid use disorder (OUD). Dispensing naloxone and medications for OUD and counseling patients about these medications are ways ...
A. Muzyk, Z. Smothers, Kathryn Collins, Mark P. MacEachern, Li-Tzy Wu   +4 more
semanticscholar   +1 more source

Comprehensive Medication Management: Implications for the Patient and Pharmacist [PDF]

, 2017
Since 1979, state pharmacy practice laws have begun to allow pharmacists to provide advanced levels of care in collaboration with prescribers. These might be termed medication therapy management, collaborative practice, comprehensive medication ...
Brayer, Hayden, Bunting, Barry, DeLucenay, Alexander, Williams, Karl   +3 more
core   +1 more source

Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells

FEBS Letters, EarlyView.
Imeglimin, at clinically relevant concentrations, inhibits vesicular ATP accumulation and release from hepatic stellate cells, thereby attenuating purinergic signaling and reducing fibrogenic activation. This mechanism reveals a newly identified antifibrotic action of imeglimin beyond glycemic control.
Seiji Nomura, Lixiang Wang, Nao Hasuzawa, Ayako Nagayama, Sawako Moriyama, Kenji Ashida, Yoshinori Moriyama, Masatoshi Nomura, Ken Yamamoto   +8 more
wiley   +1 more source

Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations.

Journal of Managed Care & Specialty Pharmacy, 2019
The shift to a value-based health care system has incentivized providers to implement strategies that improve population health outcomes while minimizing downstream costs. Given their accessibility and expanded clinical care models, community pharmacists
T. Newman, I. Hernandez, D. Keyser, Alvaro Rodríguez, E. Swart, W. Shrank, Natasha Parekh   +6 more
semanticscholar   +1 more source

Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1

FEBS Letters, EarlyView.
Vacor, a compound converted into the toxic metabolite Vacor adenine dinucleotide (VAD) by the nicotinamide salvage pathway enzymes NAMPT and NMNAT2, exhibits antitumor activity by inducing rapid and complete NAD depletion. We report that Vacor toxicity is limited to cell lines expressing high levels of SARM1, a NAD glycohydrolase.
Giuseppe Ranieri, Andrea Lapucci, Giuseppe Orsomando, Nadia Raffaelli, Alberto Chiarugi, Daniela Buonvicino   +5 more
wiley   +1 more source

The switch from patented medicine to the generic one: an option or a necessity? [PDF]

, 2018
This paper assesses the influence of a number of factors taken into account when a brand name drug is replaced by a generic one. It also evaluates responses of health professionals – physicians and pharmacist—and patients regarding the issue of switching.
Adriana Elena, Nica, Alexandra, Bolocan, Dan Nicolae, Păduraru, Daniel, Ion, Dumitru Cristinel, Badiu, Florentina, Coman, Marius, Coțofană, Octavian, Andronic, Valentin Titus, Grigorean   +8 more
core   +1 more source

Protein kinase FAM20C—when subcellular localization matters

FEBS Letters, EarlyView.
FAM20C is a Golgi‐resident kinase that phosphorylates proteins along the entire secretory pathway. The presence of potential FAM20C substrates in the cytoplasm or nucleus raises the question of how the kinase and its substrates encounter each other. Protein kinases achieve signaling specificity through consensus sequence recognition and subcellular ...
Francesca Noventa, Mauro Salvi
wiley   +1 more source

Effects of a community pharmacy-based structured medication review on drug-related problems in all-comers with polypharmacy: a randomized, controlled, double-blind, parallel-group trial

Frontiers in Medicine
BackgroundMedication reviews may help to reduce the burdens of polypharmacy. A medication review type 2a is a structured evaluation of a patient’s pharmacotherapy based on medication history and patient information in a face-to-face interview.MethodsThis
Thorsten Bischof, Alexander Schmidt-Ilsinger, Magdalena Hoppel, Anton Kreuzer, Stefanie Briganser, Philipp Saiko, Susanne Ergott-Badawi, Raimund Podroschko, Stephan Moser, Michael Kossmeier, Bernd Jilma, Stefan Deibl, Christian Schoergenhofer   +12 more
doaj   +1 more source

Pharmacists’ lack of profession-hood: Professional identity formation and its implications for practice

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2019
Background: Understanding the internalized, psychological sense of being a professional may provide important insight into understanding pharmacists’ behaviours and attitudes in practice.
P. Gregory, Z. Austin
semanticscholar   +1 more source

Exploring the role of quantitative feedback in inhaler technique education : a cluster-randomised, two-arm, parallel-group, repeated-measures study [PDF]

, 2014
Peer reviewedPublisher ...
Amin Basheti, Iman, Bosnic-Anticevich, Sinthia, Price, David, Toumas-Shehata, Mariam   +3 more
core   +2 more sources